DNACF Dena Co., Ltd. Forecast, Technical & Fundamental Analysis

DNACF in downward trend: 10-day moving average moved below 50-day moving average on September 03, 2025

The 10-day moving average for DNACF crossed bearishly below the 50-day moving average on September 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DNACF as a result. In of 48 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

DNACF moved below its 50-day moving average on September 02, 2025 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for DNACF's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for DNACF just turned positive on September 17, 2025. Looking at past instances where DNACF's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where DNACF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.905) is normal, around the industry mean (12.097). P/E Ratio (10.070) is within average values for comparable stocks, (37.436). DNACF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.372). Dividend Yield (0.015) settles around the average of (0.034) among similar stocks. P/S Ratio (1.485) is also within normal values, averaging (3.140).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DNACF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DNACF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock worse than average.